Organovo Names CFO

San Diego-based Organovo, which is developing 3D bioprinting technology, said on Tuesday that it has named Craig Kussman as the company's Chief Financial Officer. Kussman was most recently CFO of Alphaeon Corporation, and also served at XIFIN, Ascenta Therapeutics, as well as Breach Security, Discovery Partners International, Inc., SYNAVANT Inc., Cognizant Corp., and IMS Health. Organovo is publicly traded on the NYSE as ONVO.